Zobrazeno 1 - 10
of 126
pro vyhledávání: '"C. Boccafoschi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ss Maymone, C Boccafoschi, M Frongia, A Zanollo, Carlo Magno, Dario Fontana, G Montagna, U. Jacobellis, Sc Cunico, M Turriziani, M. Mari, A Martinelli
Publikováno v:
Urologia Internationalis. 70:316-320
Objectives: To determine the endocrine effects, efficacy and tolerability of the 3-month formulation of goserelin acetate (‘Zoladex’ 10.8-mg depot; ‘Zoladex’ is a trade mark of the AstraZeneca group of companies) in the treatment of patients
Autor:
Francesco Francesca, Giovanni Muto, S. Guazzieri, G. Breda, C. Boccafoschi, G. C. Comeri, Paolo Puppo, M. Perachino, Pasquale Fortunato, G.L. Pappagallo, M. Gallucci, A. Mandressi
Publikováno v:
European Urology. 33:359-364
Aim of the Study: To evaluate clinical, urodynamic efficacy and safety of TURP and TVP in patients with symptoms due to obstructive benign prostatic hypertrophy with a prospective m
Publikováno v:
Urologia Journal. 63:18-24
— After a brief description of the various and most frequent histological kinds of neoplasms of the upper urinary tract, the Authors report on the recognised and hypothetical risk factors such as Balkan nephropathy, phenacetin nephropathy, thorotra
Publikováno v:
Urologia Journal. 60:325-328
The evolution of the local inflammatory response after conclusion of BCG endovesical prophylactic treatment of superficial bladder cancer recurrences was evaluated in 12 patients. Microscopic specimens obtained during follow-up cystoscopy were examin
Autor:
F. Montefiore, C. Lozzi, G. Bottero, M. Rossi, V. Fusco, S. Treffiletti, S. Annoscia, D. Tiranti, G. Pozzi, C. Boccafoschi
Publikováno v:
Urologia Journal. 60:329-333
Twenty-two patients with operable bladder carcinoma (stage T3, T2, and T1m “high risk”), all G3–G4 except 2, have been recommended for 3 courses of methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC). Eight pathological Complete Respon
Publikováno v:
Urologia Journal. 60:320-324
The Authors report the results of a retrospective study concerning the use of mitomycin C in the prophylactic treatment of superficial bladder cancer after trans-urethral resection. The series includes 113 patients; minimum follow-up: 6 months, maxim
Publikováno v:
Urologia Journal. 60:232-243
Based on a literature review and their own personal experience, the Authors describe the usefulness of pelvic lymph node dissection in the case of bladder, prostate or penis cancer, and its four main aims: staging, cure, prophylaxis and debulking. Wh
Publikováno v:
Urologia Journal. 58:502-508
Autor:
C. Boccafoschi, S. Annoscia, Geraci E, A. Cartasegna, F. Montefiore, G. Leva, L. Contino, C. Lozzi, A. Di Mauro
Publikováno v:
Urologia Journal. 57:599-602